Basic Information
| RNALocate ID: | RLID:01001598 |
| RNA Symbol: | hsa-miR-10a-5p |
| Localization: | Cytoplasm |
RNA Information
| RNA Name: | hsa-miR-10a |
| RNA ID: | miRBase:MIMAT0000253 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24918059 |
| Tissue/Cell Line: | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) |
| Method: | Microarray |
| Description: | Data are collected from supplementary Table S1.Top-ranking nucleolar miRNAs present in HeLa and MCF7 NCode arrays. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001599 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001600 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001601 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:11001370 | Exosome | Cell lines (MCF10A|MCF-7|MDA-MB-231) | 25446899 |
| RLID:11001371 | Exosome | Renal cancer cells | 21670082 |
| RLID:11001372 | Exosome | Brain tissue | 23382797 |
| RLID:11001373 | Exosome | Plasma | 23663360 |
| RLID:11001374 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001375 | Exosome | Urine | 25135963 |
| RLID:11001376 | Exosome | Cerebrospinal fluid | 25420022 |
| RLID:11001377 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001378 | Microvesicle | Plasma | 23077538 |
| RLID:11001379 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001380 | Microvesicle | Hepatoma cells | 23771658 |
| RLID:11001381 | Microvesicle | Cerebrospinal fluid | 24797360 |
| RLID-D:11000046 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000315 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-10a-5p | Diffuse large b cell lymphoma | MNDR-E-MI-04022 |
| MNDR | hsa-miR-10a-5p | Oral squamous cell carcinoma | MNDR-E-MI-04023 |
| MNDR | hsa-miR-10a-5p | Medulloblastoma | MNDR-E-MI-04024 |
| MNDR | hsa-miR-10a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-04025 |
| MNDR | hsa-miR-10a-5p | Lymphoma | MNDR-E-MI-04026 |
| MNDR | hsa-miR-10a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-04027 |
| MNDR | hsa-miR-10a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-04028 |
| MNDR | hsa-miR-10a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-04029 |
| MNDR | hsa-miR-10a-5p | Niemann-pick disease type c | MNDR-E-MI-04030 |
| MNDR | hsa-miR-10a-5p | Dermatomyositis | MNDR-E-MI-04031 |
| MNDR | hsa-miR-10a-5p | Prostate cancer | MNDR-E-MI-04032 |
| MNDR | hsa-miR-10a-5p | Gastric cancer | MNDR-E-MI-04033 |
| MNDR | hsa-miR-10a-5p | Alzheimer disease | MNDR-E-MI-04034 |
| MNDR | hsa-miR-10a-5p | Intracranial aneurysm | MNDR-E-MI-04035 |
| MNDR | hsa-miR-10a-5p | Urinary bladder cancer | MNDR-E-MI-04036 |
| MNDR | hsa-miR-10a-5p | Dysautonomia familial | MNDR-E-MI-04037 |
| MNDR | hsa-miR-10a-5p | Polycystic ovary syndrome | MNDR-E-MI-04038 |
| MNDR | hsa-miR-10a-5p | Leukemia | MNDR-E-MI-04039 |
| MNDR | hsa-miR-10a-5p | Ataxia telangiectasia | MNDR-E-MI-04040 |
| MNDR | hsa-miR-10a-5p | Friedreich ataxia | MNDR-E-MI-04041 |
| MNDR | hsa-miR-10a-5p | Cardiovascular disease | MNDR-E-MI-04042 |
| MNDR | hsa-miR-10a-5p | Uterine fibroid | MNDR-E-MI-04043 |
| MNDR | hsa-miR-10a-5p | Lung cancer | MNDR-E-MI-04044 |
| MNDR | hsa-miR-10a-5p | Parkinson disease | MNDR-E-MI-04045 |
| MNDR | hsa-miR-10a-5p | Niemann-pick disease | MNDR-E-MI-04046 |
| MNDR | hsa-miR-10a-5p | Basal-like breast cancer | MNDR-E-MI-04047 |
| MNDR | hsa-miR-10a-5p | Thyroid cancer | MNDR-E-MI-04048 |
| MNDR | hsa-miR-10a-5p | Pancreatic cancer | MNDR-E-MI-04049 |
| MNDR | hsa-miR-10a-5p | Melanoma | MNDR-E-MI-04050 |
| MNDR | hsa-miR-10a-5p | Rectum adenocarcinoma | MNDR-E-MI-04051 |
| MNDR | hsa-miR-10a-5p | Nephroblastoma | MNDR-E-MI-04052 |
| MNDR | hsa-miR-10a-5p | Colon cancer | MNDR-E-MI-04053 |
| MNDR | hsa-miR-10a-5p | Colon adenocarcinoma | MNDR-E-MI-04054 |
| MNDR | hsa-miR-10a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-04055 |
| MNDR | hsa-miR-10a-5p | Familial ovarian cancer | MNDR-E-MI-04056 |
| MNDR | hsa-miR-10a-5p | Prostate adenocarcinoma | MNDR-E-MI-04057 |
| MNDR | hsa-miR-10a-5p | Carcinoma ductal breast | MNDR-E-MI-04058 |
| MNDR | hsa-miR-10a-5p | Glioblastoma | MNDR-E-MI-04059 |
| MNDR | hsa-miR-10a-5p | Glioma | MNDR-E-MI-04060 |
| MNDR | hsa-miR-10a-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-04061 |
| MNDR | hsa-miR-10a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-04062 |
| MNDR | hsa-miR-10a-5p | Osteosarcoma | MNDR-E-MI-04063 |
| MNDR | hsa-miR-10a-5p | Liposarcoma | MNDR-E-MI-04064 |
| MNDR | hsa-miR-10a-5p | Coronary artery disease | MNDR-E-MI-04065 |
| MNDR | hsa-miR-10a-5p | Breast carcinoma | MNDR-E-MI-04066 |
| MNDR | hsa-miR-10a-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-04067 |
| MNDR | hsa-miR-10a-5p | Liver cancer | MNDR-E-MI-04068 |
| MNDR | hsa-miR-10a-5p | Uterine cancer | MNDR-E-MI-04069 |
| MNDR | hsa-miR-10a-5p | Cervical adenocarcinoma | MNDR-E-MI-04070 |
| MNDR | hsa-miR-10a-5p | Lung squamous cell carcinoma | MNDR-E-MI-04071 |
| MNDR | hsa-miR-10a-5p | Adrenocortical carcinoma | MNDR-E-MI-04072 |
| MNDR | hsa-miR-10a-5p | Thyroid carcinoma | MNDR-E-MI-04073 |
| MNDR | hsa-miR-10a-5p | Tuberculosis | MNDR-E-MI-04074 |
| MNDR | hsa-miR-10a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-04075 |
| MNDR | hsa-miR-10a-5p | Cervical cancer | MNDR-E-MI-04076 |
| MNDR | hsa-miR-10a-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-04077 |
| MNDR | hsa-miR-10a-5p | Carcinoma renal cell | MNDR-E-MI-04078 |
| MNDR | hsa-miR-10a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-04079 |
| MNDR | hsa-miR-10a-5p | Clear cell renal cell carcinoma | MNDR-E-MI-04080 |
| MNDR | hsa-miR-10a-5p | Cholangiocarcinoma | MNDR-E-MI-04081 |
| MNDR | hsa-miR-10a-5p | Esophageal cancer | MNDR-E-MI-04082 |
| MNDR | hsa-miR-10a-5p | Oncocytoma | MNDR-E-MI-04083 |
| MNDR | hsa-miR-10a-5p | Breast invasive carcinoma | MNDR-E-MI-04084 |
| MNDR | hsa-miR-10a-5p | Hepatocellular carcinoma | MNDR-E-MI-04085 |
| MNDR | hsa-miR-10a-5p | Familiar ovarian carcinoma | MNDR-E-MI-04086 |
| MNDR | hsa-miR-10a-5p | B-cell lymphoma | MNDR-E-MI-04087 |
| MNDR | hsa-miR-10a-5p | Rheumatoid arthritis | MNDR-E-MI-04088 |
| MNDR | hsa-miR-10a-5p | Neuroblastoma | MNDR-E-MI-04089 |
| MNDR | hsa-miR-10a-5p | Chronic fatigue syndrome | MNDR-E-MI-04090 |
| MNDR | hsa-miR-10a-5p | Chronic myeloid leukemia | MNDR-E-MI-04091 |
| MNDR | hsa-miR-10a-5p | Hodgkin lymphoma | MNDR-E-MI-04092 |
| MNDR | hsa-miR-10a-5p | Neuromyelitis optica | MNDR-E-MI-04093 |
| MNDR | hsa-miR-10a-5p | Psoriasis | MNDR-E-MI-04094 |
| MNDR | hsa-miR-10a-5p | Skin cutaneous melanoma | MNDR-E-MI-04095 |
| MNDR | hsa-miR-10a-5p | Skin melanoma | MNDR-E-MI-04096 |
| MNDR | hsa-miR-10a-5p | Acute myelocytic leukemia | MNDR-E-MI-04097 |
| MNDR | hsa-miR-10a-5p | Colorectal cancer | MNDR-E-MI-04098 |
| MNDR | hsa-miR-10a-5p | Nasopharynx carcinoma | MNDR-E-MI-04099 |
| MNDR | hsa-miR-10a-5p | Multiple myeloma | MNDR-E-MI-04100 |
| MNDR | hsa-miR-10a-5p | Abortion spontaneous | MNDR-E-MI-04101 |
| MNDR | hsa-miR-10a-5p | Uterine cervical neoplasms | MNDR-E-MI-04102 |
| MNDR | hsa-miR-10a-5p | Ependymoma | MNDR-E-MI-04103 |
| MNDR | hsa-miR-10a-5p | Cardiomegaly | MNDR-E-MI-04104 |
| MNDR | hsa-miR-10a-5p | Nasopharyngeal cancer | MNDR-E-MI-04105 |
| MNDR | hsa-miR-10a-5p | Prostatic neoplasms | MNDR-E-MI-04106 |
| MNDR | hsa-miR-10a-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-04107 |
| MNDR | hsa-miR-10a-5p | Gait ataxia | MNDR-E-MI-04108 |
| MNDR | hsa-miR-10a-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-04109 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCB1 | Homo sapiens | RR00022771 |
TOP